GlassScriptPhysician profile
Jill A Goff
NPI 1811993587
$2,442.91
in general payments reported to CMS, 2019-2025
23 companies · $539 in 2025
The $539 reported for 2025 was more than what 85% of Obstetrics & Gynecology (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Obstetrics & Gynecology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $371 · 2022: $520 · 2023: $596 · 2024: $417 · 2025: $539.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,553.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,552.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $452.75 | 2022-2025 | |
| Astellas Pharma US INC | $236.47 | 2021-2025 | Veozah |
| Mayne Pharma Commercial LLC | $201.77 | 2021-2025 | |
| Biogen, INC. | $194.42 | 2024-2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $192.86 | 2023-2025 | Myfembree |
| Coopersurgical, INC. | $148.80 | 2021-2024 | Paragard T 380a, Paragard T 380a |
| Therapeuticsmd, INC. | $99.99 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $94.05 | 2021-2025 | Gardasil 9, Gardasil |
| Exeltis, USA INC. | $93.50 | 2021-2025 | Slynd |
| Channel Medsystems, INC. | $92.66 | 2023 | |
| Pfizer INC. | $85.77 | 2021-2023 | |
| Optumhealth Care Solutions, LLC | $77.21 | 2023-2025 | Vivify Health Care Team Portal 001, Eitan Medical, Vivify Health Care Team Portal |
| Scynexis, INC. | $70.67 | 2022 | |
| Organon LLC | $67.01 | 2021-2025 | Nexplanon |
| Hologic Sales and Service, LLC | $52.20 | 2021-2024 | Aptima |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $43.53 | 2021 | |
| Myovant Sciences INC. | $42.07 | 2021-2022 | |
| Avion Pharmaceuticals | $41.70 | 2021-2022 | |
| Daiichi Sankyo INC. | $41.51 | 2021-2022 | |
| Agile Therapeutics, INC. | $39.57 | 2021-2023 | Twirla |
| Bayer Healthcare Pharmaceuticals INC. | $37.32 | 2025 | |
| Evofem Biosciences, INC. | $22.69 | 2021 | |
| Lupin INC. | $14.39 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jill Goff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.